MACOMPTA.fr (MLCMA) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
15 Apr, 2026Executive summary
Achieved strong sales growth in Q3 of fiscal year 2025/2026, with revenue of €1,454.4K, representing a 28.1% increase year-over-year.
Financial highlights
Q3 sales reached €1,454.4K, up from €1,135.8K in the same quarter last year, marking a 28.1% year-over-year increase.
Outlook and guidance
Next sales publication scheduled for Q4 on July 15, 2026.
Partial view of Summaries dataset, powered by Quartr API
Latest events from MACOMPTA.fr
- Q1 revenue rose 34% as ARR grew 36.9%; FY26/27 targets reaffirmed.MLCMA
Q1 2027 TU - Revenue grew 28.1%; FY 2026/2027 guidance targets 28%–35% growth.MLCMA
H2 2026 - Revenue and net income surged, with key milestones and a major tax dispute ongoing.MLCMA
H2 2024 - Full-year revenue grew 28.1% to €5,205K, led by strong gains in all segments.MLCMA
Q4 2026 TU - Revenue up 29% with 19% EBITDA margin; robust R&D and new launches drive future growth.MLCMA
H1 2026 - Q2 sales surged 29.5% year-over-year to €1,120K, driven by robust platform adoption.MLCMA
Q2 2026 TU - 28.6% revenue growth, higher EBITDA, strong cash, no debt, and a €325K dividend proposed.MLCMA
H2 2025 - Q1 revenue surged 28.4% year-over-year, reaching €1,035.4K.MLCMA
Q1 2026 TU - Q1 revenue up 30% year-over-year, confirming strong growth for macompta.fr.MLCMA
Q1 2025 TU